Industry
In a significant move to expand its immuno-oncology portfolio, Boehringer Ingelheim has acquired T3 Pharmaceuticals AG, a Swiss biotech company specializing in bacterial cancer therapy.
Epatrex, a new nutraceutical compound formulated as a three-layer tablet containing the probiotic Lactobacillus casei LC-XCAL.
The therapy, combining human milk oligosaccharides (HMOs) and a specific gut bacteria strain, represents not only a scientific breakthrough but also holds substantial economic implications.
Industry
Sponsored by
Smiling ear to ear, supporting healthy teeth and mouth.
Industry
Sponsored by
This approval marks a significant leap forward in our understanding of holistic health and the intricate connection between our guts and our brains.
In Europe the probiotics sector is facing a lack of harmonization and a near-total veto on any health claims. What happened, where are we now, and what can we hope…
Bone resorption increases the risk of osteopenia and osteoporosis during and after menopause – learn about the importance of the gut microbiota to support healthy bones.
Nestlé, a global leader in nutrition and wellness, is taking a giant leap forward in early-life nutrition with its latest innovation – Sinergity.
Industry
Sponsored by
The acquisition brings together two complementary forces, continue to respond to customer needs and help their growth with their respective strengths.
Industry
Sponsored by
Lallemand launches Expert’Biome™ CDMO to support partners in their development of next-generation strains.
